Standout Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone f... 2019 2026 2021 2023 349
  1. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion (2019)
    Minke He, QiJiong Li et al. JAMA Oncology

Immediate Impact

1 by Nobel laureates 72 standout
Sub-graph 1 of 22

Citing Papers

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
5 intermediate papers

Works of Yong Le being referenced

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
2019 Standout

Author Peers

Author Last Decade Papers Cites
Yong Le 443 111 125 211 184 11 617
MinShan Chen 418 78 111 225 164 9 549
Chiara Cristofori 379 65 105 147 145 13 525
Roberto Ragazzi 357 61 105 146 167 14 571
Diyang Xie 416 101 138 108 141 9 602
Kiminori Uka 415 49 141 86 225 14 572
Herman Wong 415 184 158 140 88 14 638
Donald Poon 242 255 222 171 103 19 681
Luwen Mu 385 79 221 142 163 23 629
Clive Stubbs 309 33 172 145 207 16 541
Touraj Mansourbakht 221 77 260 117 110 14 615

All Works

Loading papers...

Rankless by CCL
2026